in this issue
Regions :: China
Merck KGaA to invest €80 million to build pharmaceutical facility in China
11:38 AM MST | November 15, 2013 | Deepti Ramesh
Merck KGaA (Darmstadt, Germany) says its biopharmaceutical division Merck Serono (Darmstadt), will invest €80 million ($107 million) to build a new pharmaceutical manufacturing facility in the Nantong Economical Technological Development Area, in the Greater Shanghai region. The facility will focus on the bulk production and packaging of Glucophage, Concor, and Euthyrox, Merck’s brands for the treatment of diabetes, cardiovascular diseases, and thyroid disorders, respectively. Construction on the facility is scheduled to start in 2014 and will be...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee